Vicente E. Torres
Division of Nephrology and Hypertension
Department of Internal Medicine
Mayo Clinic
Rochester
USA
Name/email consistency: high
- Tolvaptan in patients with autosomal dominant polycystic kidney disease. Torres, V.E., Chapman, A.B., Devuyst, O., Gansevoort, R.T., Grantham, J.J., Higashihara, E., Perrone, R.D., Krasa, H.B., Ouyang, J., Czerwiec, F.S. N. Engl. J. Med. (2012)
- Insignificant effect of secretin in rodent models of polycystic kidney and liver disease. Wang, X., Ye, H., Ward, C.J., Chu, J.Y., Masyuk, T.V., Larusso, N.F., Harris, P.C., Chow, B.K., Torres, V.E. Am. J. Physiol. Renal Physiol. (2012)
- Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Irazabal, M.V., Huston, J., Kubly, V., Rossetti, S., Sundsbak, J.L., Hogan, M.C., Harris, P.C., Brown, R.D., Torres, V.E. Clin. J. Am. Soc. Nephrol (2011)
- Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Torres, V.E., Grantham, J.J., Chapman, A.B., Mrug, M., Bae, K.T., King, B.F., Wetzel, L.H., Martin, D., Lockhart, M.E., Bennett, W.M., Moxey-Mims, M., Abebe, K.Z., Lin, Y., Bost, J.E. Clin. J. Am. Soc. Nephrol (2011)
- Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Torres, V.E., Boletta, A., Chapman, A., Gattone, V., Pei, Y., Qian, Q., Wallace, D.P., Weimbs, T., Wüthrich, R.P. Clin. J. Am. Soc. Nephrol (2010)
- Treatment strategies and clinical trial design in ADPKD. Torres, V.E. Adv. Chronic. Kidney. Dis (2010)
- A case for water in the treatment of polycystic kidney disease. Torres, V.E., Bankir, L., Grantham, J.J. Clin. J. Am. Soc. Nephrol (2009)
- Vasopressin in chronic kidney disease: an elephant in the room? Torres, V.E. Kidney Int. (2009)
- Autosomal dominant polycystic kidney disease: the last 3 years. Torres, V.E., Harris, P.C. Kidney Int. (2009)
- Role of vasopressin antagonists. Torres, V.E. Clin. J. Am. Soc. Nephrol (2008)
- Vasopressin antagonists in polycystic kidney disease. Torres, V.E. Semin. Nephrol. (2008)
- Update on autosomal dominant polycystic kidney disease. Torres, V.E., Rossetti, S., Harris, P.C. Minerva Med. (2007)
- Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Torres, V.E., King, B.F., Chapman, A.B., Brummer, M.E., Bae, K.T., Glockner, J.F., Arya, K., Risk, D., Felmlee, J.P., Grantham, J.J., Guay-Woodford, L.M., Bennett, W.M., Klahr, S., Meyers, C.M., Zhang, X., Thompson, P.A., Miller, J.P. Clin. J. Am. Soc. Nephrol (2007)
- Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. Torres, V.E., Harris, P.C. J. Intern. Med. (2007)
- Autosomal dominant polycystic kidney disease. Torres, V.E., Harris, P.C., Pirson, Y. Lancet (2007)
- Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Torres, V.E., Harris, P.C. Nature Clinical Practice. Nephrology (2006)
- Vasopressin antagonists in polycystic kidney disease. Torres, V.E. Kidney Int. (2005)
- Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Torres, V.E., Wang, X., Qian, Q., Somlo, S., Harris, P.C., Gattone, V.H. Nat. Med. (2004)
- Therapies to slow polycystic kidney disease. Torres, V.E. Nephron Exp. Nephrol. (2004)
- Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Torres, V.E., Sweeney, W.E., Wang, X., Qian, Q., Harris, P.C., Frost, P., Avner, E.D. Kidney Int. (2004)
- Autosomal dominant polycystic kidney disease. Torres, V.E., Harris, P.C. Nefrologia (2003)
- Vascular expression of polycystin-2. Torres, V.E., Cai, Y., Chen, X., Wu, G.Q., Geng, L., Cleghorn, K.A., Johnson, C.M., Somlo, S. J. Am. Soc. Nephrol. (2001)
- Long-term ammonium chloride or sodium bicarbonate treatment in two models of polycystic kidney disease. Torres, V.E., Cowley, B.D., Branden, M.G., Yoshida, I., Gattone, V.H. Exp. Nephrol. (2001)
- Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats. Torres, V.E., Bengal, R.J., Nickander, K.K., Grande, J.P., Low, P.A. Am. J. Kidney Dis. (1998)
- Inherited renal neoplasms. Torres, V.E., Bjornsson, J., Zincke, H. J. Nephrol. (1998)
- Renal manifestations of tuberous sclerosis complex. Torres, V.E., Zincke, H., King, B.K., Bjornsson, J. Contrib. Nephrol (1997)